XmAb5574

· Xencor, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for XmAb5574, covering 2014-04-21 to 2014-04-21. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Tolerability of XmAb®5574 in Chronic Lymphocytic Leukemia [Phase 1]